Boule Diagnostics AB (publ)

kr 1.22As of Sun 8 Nov 2026, 12:00 UTC
STO:BOULHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (25.98%)
Div yield —
ROE (10.36%)
Medical Devices
Beta (5Y) 0.32
PE TTM —
TSR TTM (80.88%)
Mkt cap kr 47.38M
ROIC 2.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.25
2.69%
(80.57%)
Hold 3|8|6|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.02
0.02
0.02
0.02
7.89%
16.00%
34.94%
37.83%
Revenuekr M
2.440
2.381
2.464
2.525
2.89%
(3.86%)
0.07%
0.67%
Peers (US$4.790M)
Cap (US$)
PE
5.698M
—
4.676M
—
Capital
TTM
5Y
10Y
Leveragex
1.480
(0.145)
(0.100)
EBIT/Intx
0.313
0.801
0.615
Own earn%
(184.49)
(7.10)
(2.14)
Sh yield%
24.12
28.38
31.28
Owners
Insiders/Inst%
4.40
78.69
Short interest%
2.31
SBC / revenue%
0.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
11–17
$1 testx
0.1
Incr. ROIC%
12